Dr. Le Du, founder of UNISKIN, graduated Summa Cum Laude with College Honors from the University of California, Los Angeles (UCLA), where he majored in Molecular, Cell, and Developmental Biology. He went on to earn his Doctor of Medicine (M.D.) degree in New York and began his clinical career as an internal medicine physician at Harbor-UCLA Medical Center in Los Angeles.

In late 2016, Dr. Du returned to China and founded UNISKIN, a skincare brand dedicated to researching skin aging in Chinese populations. The brand’s R&D philosophy is deeply rooted in Dr. Du’s medical background, shaped by his clinical observations and understanding of the significant relationship between ethnic diversity and physiological expression. Since its inception, UNISKIN has maintained a strong commitment to scientific research and academic rigor, aiming to develop products tailored to the unique characteristics of Chinese skin through a deeper understanding and study of these differences.

UNISKIN has independently published over ten international SCI (Science Citation Index) papers and, in 2022, led the development and release of the Standards for the Evaluation of Human Skin Aging, specifically focused on Chinese individuals.

As SVP of China Business Innovation & Investment office for Shiseido created in January 2019, Carol is helping to shape the next phase of transformation for the company. By leveraging the dynamic ecosystem and entrepreneurial talents in China, Carol will help to accelerate the implementations of innovations and new business models, to create a new beauty business as the next growth driver of the Shiseido group on a global level. Previously, she has held a number of management positions at multinational firms such as Unilever, Burberry, L’Oréal, and Marriott where she has led global strategy & innovation functions across regions and categories.

Carol received her undergraduate degree from New York University's Stern Business School and her MBA from Hong Kong University of Science and Technology.